Antibody persistence up to 26 months after booster dosing in adolescents 4 years following a 2- and 3-dose primary vaccination series of menb-fhbp
ESPID Education. Maguire J. 05/09/19; 263128 Disclosure(s)(s): Pfizer employee
Dr. Jason D. Maguire
Dr. Jason D. Maguire
Members: Login with your ESPID members credentials.

Non-Members: Create a Free ESPID Guest account here and use the “Guest Access” button to login and access Regular content.
Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies